Palatin Technologies, Inc.(PTN)
Biotechnology
Immunology & Autoimmune Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-12-29 | WILLS STEPHEN T Executive VP and CFO/COO | Sale | -565 | -0.88%63,488 | $16.74 | $9,461 | View SEC filing | |
| 2025-06-17 | WILLS STEPHEN T Executive VP and CFO/COO | Purchase | +2,728,772 | +141.40%4,658,594 | $82.45 | $225,000,000 | View SEC filing | |
| 2025-06-17 | SPANA CARL President and CEO | Purchase | +2,728,772 | +136.11%4,733,595 | $82.45 | $225,000,000 | View SEC filing | |
| 2025-06-17 | DUNTON ALAN W Director | Purchase | +363,836 | +129.81%644,128 | $10.99 | $4,000,000 | View SEC filing | |
| 2025-05-12 | DEVEER ROBERT K JR Director | Purchase | +100,000 | +262.71%138,065 | $0.10 | $10,180 | View SEC filing | |
| 2024-08-02 | WILLS STEPHEN T Executive VP and CFO/COO | Sale | -4,999 | -2.08%235,456 | $1.66 | $8,274 | View SEC filing | |
| 2024-04-11 | DEVEER ROBERT K JR Director | Purchase | +6,000 | +17.22%40,845 | $2.12 | $12,703 | View SEC filing | |
| 2024-03-07 | DEVEER ROBERT K JR Director | Sale | -11,700 | -25.14%34,845 | $2.00 | $23,434 | View SEC filing | |
| 2023-12-08 | WILLS STEPHEN T Executive VP and CFO/COO | Sale | -4,998 | -1.50%327,522 | $2.51 | $12,563 | View SEC filing | |
| 2023-12-06 | DUNTON ALAN W Director | Sale | -200 | -0.44%45,074 | $2.48 | $496 | View SEC filing | |
| 2022-12-28 | SPANA CARL President and CEO | Purchase | +10,000 | +3.53%293,604 | $2.23 | $22,297 | View SEC filing | |
| 2022-12-28 | WILLS STEPHEN T Executive VP and CFO/COO | Purchase | +10,000 | +3.89%267,101 | $2.22 | $22,245 | View SEC filing | |
| 2022-12-23 | DUNTON ALAN W Director | Sale | -200 | -0.48%41,420 | $2.97 | $594 | View SEC filing | |
| 2021-07-02 | Morris Arlene Director | Purchase | +33,000 | +4.96%698,666 | $0.62 | $20,460 | View SEC filing | |
| 2021-07-02 | Hull Joseph Stanley Director | Purchase | +10,000 | +1.31%775,966 | $0.61 | $6,100 | View SEC filing | |
| 2021-07-02 | DUNTON ALAN W Director | Purchase | +20,000 | +2.61%786,518 | $0.62 | $12,350 | View SEC filing | |
| 2021-07-02 | SPANA CARL President and CEO | Purchase | +75,000 | +0.87%8,705,051 | $0.62 | $46,394 | View SEC filing | |
| 2021-07-02 | WILLS STEPHEN T Executive VP and CFO/COO | Purchase | +75,000 | +0.98%7,734,696 | $0.62 | $46,238 | View SEC filing | |
| 2020-11-30 | DEVEER ROBERT K JR Director | Purchase | +54,000 | +8.00%728,638 | $0.41 | $22,140 | View SEC filing | |
| 2020-10-02 | DEVEER ROBERT K JR Director | Sale | -54,000 | -7.74%643,472 | $0.46 | $24,980 | View SEC filing | |
| 2019-08-07 | Hull Joseph Stanley Director | Purchase | +800 | +0.15%520,799 | $0.78 | $627 | View SEC filing | |
| 2019-08-05 | WILLS STEPHEN T Executive VP and CFO/COO | Purchase | +50,000 | +0.95%5,314,239 | $0.86 | $43,250 | View SEC filing | |
| 2019-08-05 | DEVEER ROBERT K JR Director | Purchase | +22,580 | +4.14%568,139 | $0.86 | $19,419 | View SEC filing | |
| 2019-08-05 | SPANA CARL President and CEO | Purchase | +50,000 | +0.84%5,993,852 | $0.86 | $43,119 | View SEC filing | |
| 2018-11-21 | Morris Arlene Director | Purchase | +12,000 | +4.33%288,999 | $0.69 | $8,223 | View SEC filing |
1-25 of 63